BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23190897)

  • 1. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.
    Paulson KG; Iyer JG; Blom A; Warton EM; Sokil M; Yelistratova L; Schuman L; Nagase K; Bhatia S; Asgari MM; Nghiem P
    J Invest Dermatol; 2013 Mar; 133(3):642-646. PubMed ID: 23190897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
    J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study.
    Paulson KG; Iyer JG; Simonson WT; Blom A; Thibodeau RM; Schmidt M; Pietromonaco S; Sokil M; Warton EM; Asgari MM; Nghiem P
    Am J Clin Pathol; 2014 Oct; 142(4):452-8. PubMed ID: 25239411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
    Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
    J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
    Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
    J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival.
    Cook M; Baker K; Redman M; Lachance K; Nguyen MH; Parvathaneni U; Bhatia S; Nghiem P; Tseng YD
    Am J Clin Oncol; 2019 Jan; 42(1):82-88. PubMed ID: 30211723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.
    Lewis CW; Qazi J; Hippe DS; Lachance K; Thomas H; Cook MM; Juhlin I; Singh N; Thuesmunn Z; Takagishi SR; McEvoy A; Doolittle-Amieva C; Bhatia S; Paulson KG; O'Malley RB; Wang CL; Nghiem P
    Cancer Med; 2020 Feb; 9(4):1374-1382. PubMed ID: 31883234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.
    Stetsenko GY; Malekirad J; Paulson KG; Iyer JG; Thibodeau RM; Nagase K; Schmidt M; Storer BE; Argenyi ZB; Nghiem P
    Am J Clin Pathol; 2013 Dec; 140(6):838-44. PubMed ID: 24225752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
    Arron ST; Canavan T; Yu SS
    J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
    van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
    J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort study.
    Bleicher J; Asare EA; Flores S; Bowles TL; Bowen GM; Hyngstrom JR
    Am J Surg; 2021 Apr; 221(4):844-849. PubMed ID: 32878692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.
    Lemos BD; Storer BE; Iyer JG; Phillips JL; Bichakjian CK; Fang LC; Johnson TM; Liegeois-Kwon NJ; Otley CC; Paulson KG; Ross MI; Yu SS; Zeitouni NC; Byrd DR; Sondak VK; Gershenwald JE; Sober AJ; Nghiem P
    J Am Acad Dermatol; 2010 Nov; 63(5):751-61. PubMed ID: 20646783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
    Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Kraus DH; Brady MS; Coit DG
    Ann Surg Oncol; 2011 Sep; 18(9):2529-37. PubMed ID: 21431988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.
    Laude HC; Jonchère B; Maubec E; Carlotti A; Marinho E; Couturaud B; Peter M; Sastre-Garau X; Avril MF; Dupin N; Rozenberg F
    PLoS Pathog; 2010 Aug; 6(8):e1001076. PubMed ID: 20865165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
    Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
    J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma.
    Kang SH; Haydu LE; Goh RY; Fogarty GB
    Radiat Oncol; 2012 Oct; 7():171. PubMed ID: 23075308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival in women versus men with merkel cell carcinoma.
    Tam M; Luu M; Barker CA; Gharavi NM; Hamid O; Shiao SL; Nguyen AT; Lu DJ; Ho AS; Zumsteg ZS
    J Am Acad Dermatol; 2021 Feb; 84(2):321-329. PubMed ID: 32423829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.
    Blom A; Bhatia S; Pietromonaco S; Koehler K; Iyer JG; Nagase K; Paulson K; Sabath DE; Nghiem P
    J Am Acad Dermatol; 2014 Mar; 70(3):449-55. PubMed ID: 24388423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection.
    Moshiri AS; Doumani R; Yelistratova L; Blom A; Lachance K; Shinohara MM; Delaney M; Chang O; McArdle S; Thomas H; Asgari MM; Huang ML; Schwartz SM; Nghiem P
    J Invest Dermatol; 2017 Apr; 137(4):819-827. PubMed ID: 27815175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.